TAG ARCHIVES FOR NIH

22
Jan2013

by Mindy Reeter, BS, CIP, Associate Director of the Office for Human Research Oversight at the University of Illinois College of Medicine at Peoria

As a human subjects protections professional, my children have always been exposed to medical research, and as consumers who utilize teaching hospitals and clinics for healthcare, my family has received our fair share of consent/assent forms inviting us to participate in research.

I [...] Read more

29
Feb2012

by Andrew N Rowan, PhD, Chief Scientific Officer of The Humane Society of the United States, PRIM&R Board Member, 1985-2010

The use of chimpanzees in invasive experiments has been a controversial issue for decades with proponents arguing that chimpanzee use is necessary to advance human health and opponents arguing that the practice is both unnecessary and unethical. Recent developments could lead to a possible resolution of this issue.

A National Academies’ Institute of Medicine (IOM) committee spent approximately eight months last year examining the necessity of using chimpanzees in biomedical and behavioral research. The Read more

2
May2011

We are pleased to welcome guest blogger Melinda Abelman, MSc, CIP, Embryonic Stem Cell Research Oversight manager at Partners HealthCare System, to Ampersand. Below, Ms. Abelman shares her view on the most recent federal decision regarding stem cell research.

As the embryonic stem cell research oversight (ESCRO) manager for an academic institution, I routinely monitor local, national, and [...] Read more

21
May2009

IBC Conference: June 24-26

Tags:
No comments

Collaboration between IRBs and IBCs offers immediate and long-term benefits—especially when it comes to reviewing human gene transfer research projects. This effort not only ensures that regulatory requirements are met, but that risks and potential benefits are clearly communicated to research participants.

So, where might you begin bridging the gap? You could start by attending Institutional Biosafety Committees: Promoting Optimal Practice Now and in the Future. Hosted by the National Institutes of Health Office of Biotechnology Activities (NIH OBA) and the Eagleson Institute on June 24-26, this meeting aims to help biosafety professionals expand their knowledge of research [...] Read more

Page 8 of 8« First...45678